Virax Biolabs Group Limited, a Cayman Islands exempted company incorporated on September 2, 2021, is a global innovative biotechnology group engaged in the sales, distribution and marketing of diagnostic kits, medical technology and personal protective equipment products for the prevention, detection, diagnosis and risk management of viral diseases, with a particular focus on the field of immunology, The product portfolio includes: (i) diagnostic test kits sold through its "ViraxClear" brand; (ii) medical technology and PPE products sold through its "ViraxCare" brand; and (iii) sourcing brands, and also expects to launch a brand "Virax Immune", which aims to provide an immunological analysis platform to assess each person's immune risk profile against major viral diseases worldwide.
